Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 57, Issue 5, Pages 547-557
Publisher
Wiley
Online
2016-09-27
DOI
10.1002/jcph.834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment
- (2016) Priska Kaufmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male Subjects
- (2016) Shirin Bruderer et al. CLINICAL THERAPEUTICS
- Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
- (2015) Priska Kaufmann et al. American Journal of Cardiovascular Drugs
- Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects
- (2015) Priska Kaufmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Bioequivalence of different dose-strength tablets of selexipag, a selective prostacyclin receptor agonist, in a multiple-dose up-titration study
- (2015) Daniela Baldoni et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Selexipag for the Treatment of Pulmonary Arterial Hypertension
- (2015) Olivier Sitbon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary hypertension: diagnostic and therapeutic challenges
- (2015) Wassim Fares et al. Therapeutics and Clinical Risk Management
- Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects
- (2014) Shirin Bruderer et al. PHARMACOLOGY
- A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist
- (2014) Matthias Hoch et al. Drug Design Development and Therapy
- Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)
- (2013) Victor F. Tapson et al. CHEST
- Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension
- (2013) Zhi-Cheng Jing et al. CIRCULATION
- Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins
- (2013) N.N. Orie et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
- (2012) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: The impact of late referral
- (2012) Roberto Badagliacca et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy
- (2011) Jean-Luc Vachiéry ADVANCES IN THERAPY
- Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension
- (2011) Md. Talat Nasim et al. HUMAN MUTATION
- Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
- (2010) Hossein A. Ghofrani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- At the heart of tissue: endothelin system and end-organ damage
- (2010) Marc Iglarz et al. CLINICAL SCIENCE
- Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
- (2010) H. A. Ghofrani et al. EUROPEAN RESPIRATORY JOURNAL
- Selexipag: A Selective Prostacyclin Receptor Agonist that Does Not Affect Rat Gastric Function
- (2010) K. Morrison et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Long-term therapy with inhaled iloprost in patients with pulmonary hypertension
- (2010) Horst Olschewski et al. RESPIRATORY MEDICINE
- Tadalafil Therapy for Pulmonary Arterial Hypertension
- (2009) Nazzareno Galiè et al. CIRCULATION
- End Points and Clinical Trial Design in Pulmonary Arterial Hypertension
- (2009) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetics and Genomics of Pulmonary Arterial Hypertension
- (2009) Rajiv D. Machado et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnosis and Assessment of Pulmonary Arterial Hypertension
- (2009) David B. Badesch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
- (2009) Kamal K. Mubarak RESPIRATORY MEDICINE
- Endothelin receptor antagonists in pulmonary arterial hypertension
- (2008) J. Dupuis et al. EUROPEAN RESPIRATORY JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started